Lowery, M. M., Hill, N. S., Wang, L., Rosenzweig, E. B., Bhat, A., Erzurum, S., Finet, J. E., Jellis, C. L., Kaur, S., Kwon, D. H., Nawabit, R., Radeva, M., Beck, G. J., Frantz, R. P., Hassoun, P. M., Hemnes, A. R., Horn, E. M., Leopold, J. A., Rischard, F. P., … Page, G. (2023). Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension. Journal of the American College of Cardiology, 82(21), 1989–2005. https://doi.org/10.1016/j.jacc.2023.09.806

Welch, C. L., Aldred, M. A., Balachandar, S., Dooijes, D., Eichstaedt, C. A., Gräf, S., Houweling, A. C., Machado, R. D., Pandya, D., Prapa, M., Shaukat, M., Southgate, L., Tenorio-Castano, J., Callejo, E. P., Day, K. M., Macaya, D., Maldonado-Velez, G., Chung, W. K., Archer, S. L., … Zateyshchikov, D. (2023). Defining the clinical validity of genes reported to cause pulmonary arterial hypertension. Genetics in Medicine, 25(11), 100925. https://doi.org/10.1016/j.gim.2023.100925

Avitabile, C. M., Yung, D., Handler, S., Hopper, R. K., Fineman, J., Freire, G., Varghese, N., Mullen, M. P., Krishnan, U. S., Austin, E., Silveira, L., & Ivy, D. D. (2023). Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial Hypertension. The Journal of Pediatrics, 262, 113639. https://doi.org/10.1016/j.jpeds.2023.113639

Rosenzweig, E., Villeda, G. A. V., Crook, S., Koli, F., Rosenzweig, E. B., & Krishnan, U. S. (2023). Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study. Texas Heart Institute Journal, 50(5). https://doi.org/10.14503/thij-22-7866

Kailas, M., Layton, A. M., Pesce, M., Liberman, L., Starc, T. J., Fremed, M. A., Garofano, R., Rosenzweig, E. B., & Krishnan, U. S. (2023). Exercise-Induced Electrocardiography Changes in Pulmonary Arterial Hypertension. The American Journal of Cardiology, 208, 60–64. https://doi.org/10.1016/j.amjcard.2023.09.014

Simpson, C. E., Ambade, A. S., Harlan, R., Roux, A., Aja, S., Graham, D., Shah, A. A., Hummers, L. K., Hemnes, A. R., Leopold, J. A., Horn, E. M., Berman-Rosenzweig, E. S., Grunig, G., Aldred, M. A., Barnard, J., Comhair, S. A. A., Tang, W. H. W., Griffiths, M., … Rischard, F. (2023). Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology, 325(5), L617–L627. https://doi.org/10.1152/ajplung.00177.2023

Heller, S., See, C., Singh, I., & Fredericks, C. A. (2023). Cognitive impairment in pulmonary arterial hypertension. Annals of Clinical and Translational Neurology, 10(10), 1899–1903. Portico. https://doi.org/10.1002/acn3.51867

Rischard, F. P., Bernardo, R. J., Vanderpool, R. R., Kwon, D. H., Acharya, T., Park, M. M., Katrynuik, A., Insel, M., Kubba, S., Badagliacca, R., Larive, A. B., Naeije, R., Garcia, J. G. N., Beck, G. J., Erzurum, S. C., Frantz, R. P., Hassoun, P. M., Hemnes, A. R., Hill, N. S., … Wilcox, J. D. (2023). Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension. Circulation: Heart Failure, 16(10). https://doi.org/10.1161/circheartfailure.123.010555

Eichstaedt, C. A., Belge, C., Chung, W. K., Gräf, S., Grünig, E., Montani, D., Quarck, R., Tenorio-Castano, J. A., Soubrier, F., Trembath, R. C., & Morrell, N. W. (2022). Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH. European Respiratory Journal, 61(2), 2201471. https://doi.org/10.1183/13993003.01471-2022

Woo, J. L., DiLorenzo, M. P., Rosenzweig, E., Pasumarti, N., Villeda, G. V., Berman-Rosenzweig, E., & Krishnan, U. (2022). Correlation Between Right Ventricular Echocardiography Measurements and Functional Capacity in Patients With Pulmonary Arterial Hypertension. Texas Heart Institute Journal, 49(6). https://doi.org/10.14503/thij-21-7719

Redel-Traub, G., Sampson, K. J., Kass, R. S., & Bohnen, M. S. (2022). Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension. Biomolecules, 12(10), 1341. https://doi.org/10.3390/biom12101341

Machado, R. D., Welch, C. L., Haimel, M., Bleda, M., Colglazier, E., Coulson, J. D., Debeljak, M., Ekstein, J., Fineman, J. R., Golden, W. C., Griffin, E. L., Hadinnapola, C., Harris, M. A., Hirsch, Y., Hoover-Fong, J. E., Nogee, L., Romer, L. H., Vesel, S., … Chung, W. K. (2021). Biallelic variants of ATP13A3 cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality. Journal of Medical Genetics, 59(9), 906–911. https://doi.org/10.1136/jmedgenet-2021-107831

Chang, K. Y., Duval, S., Badesch, D. B., Bull, T. M., Chakinala, M. M., De Marco, T., Frantz, R. P., Hemnes, A., Mathai, S. C., Rosenzweig, E. B., Ryan, J. J., Thenappan, T., Allen, R., Bartolome, S., Benza, R., Cadaret, L., Eggert, M., Elwing, J., Fineman, J., … Zwicke, D. (2022). Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. Journal of the American Heart Association, 11(9). https://doi.org/10.1161/jaha.121.024969

Welch, C. L., & Chung, W. K. (2022). Channelopathy Genes in Pulmonary Arterial Hypertension. Biomolecules, 12(2), 265. https://doi.org/10.3390/biom12020265